Cargando…

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection

Tuberculosis (TB) has huge impact on human morbidity and mortality and biomarkers to support rapid TB diagnosis and ensure treatment initiation and cure are needed, especially in regions with high prevalence of multi-drug resistant TB. Soluble interferon gamma inducible protein 10 (IP-10) analyzed f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tonby, Kristian, Ruhwald, Morten, Kvale, Dag, Dyrhol-Riise, Anne Ma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363864/ https://www.ncbi.nlm.nih.gov/pubmed/25783975 http://dx.doi.org/10.1038/srep09223

Ejemplares similares

IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting
por: Hoel, Ida Marie, et al.
Publicado: (2019)

The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2016)

Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
por: Lieske, Nora V., et al.
Publicado: (2015)

Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper
por: Aabye, Martine G., et al.
Publicado: (2013)

Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
por: Feruglio, S L, et al.
Publicado: (2015)

A Simple Method to Quantitate IP-10 in Dried Blood and Plasma Spots
por: Aabye, Martine G., et al.
Publicado: (2012)

IP-10 Can Be Measured in Dried Plasma Spots in Patients with Chronic Hepatitis C Infection
por: Ruhwald, Morten, et al.
Publicado: (2012)

Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease
por: Nore, Kristin Grotle, et al.
Publicado: (2020)

A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
por: Jenum, Synne, et al.
Publicado: (2021)

DIAGNOSTIC ACCURACY AND ADDED VALUE OF INFECTION BIOMARKERS IN PATIENTS WITH POSSIBLE SEPSIS IN THE EMERGENCY DEPARTMENT
por: Christensen, Erik E., et al.
Publicado: (2022)

Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2021)

Use of IP-10 detection in dried plasma spots for latent tuberculosis infection diagnosis in contacts via mail
por: Villar-Hernández, R., et al.
Publicado: (2019)

Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail
por: Neesgaard, Bastian, et al.
Publicado: (2018)

Soluble Markers of the Toll-Like Receptor 4 Pathway Differentiate between Active and Latent Tuberculosis and Are Associated with Treatment Responses
por: Feruglio, Siri L., et al.
Publicado: (2013)

A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries
por: Chendi, Bih H., et al.
Publicado: (2021)

Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls
por: Wergeland, Ida, et al.
Publicado: (2016)

Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice
por: Mortensen, Rasmus, et al.
Publicado: (2019)

Regulation of Gag- and Env-Specific CD8(+) T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy
por: Prebensen, Christian, et al.
Publicado: (2016)

Monocytic myeloid‐derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase‐2 inhibitors
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
por: Brekke, Kristin, et al.
Publicado: (2017)

IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay
por: Ruhwald, Morten, et al.
Publicado: (2009)

Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
por: Prebensen, Christian, et al.
Publicado: (2017)

Evaluation of the filter paper IP-10 tests in school children after exposure to tuberculosis: a prospective cohort study with a 4-year follow-up
por: Tuuminen, Tamara, et al.
Publicado: (2012)

Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteria
por: Heyckendorf, Jan, et al.
Publicado: (2020)

Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions
por: Blauenfeldt, Thomas, et al.
Publicado: (2018)

Improving T-Cell Assays for the Diagnosis of Latent TB Infection: Potential of a Diagnostic Test Based on IP-10
por: Ruhwald, Morten, et al.
Publicado: (2008)

High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections
por: Quist-Paulsen, Else, et al.
Publicado: (2018)

Development of a One-Step Probe Based Molecular Assay for Rapid Immunodiagnosis of Infection with M. tuberculosis Using Dried Blood Spots
por: Blauenfeldt, Thomas, et al.
Publicado: (2014)

Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results
por: Gran, Gerd, et al.
Publicado: (2013)

Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient
por: Eldholm, Vegard, et al.
Publicado: (2014)

Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis
por: Jensen, Christina, et al.
Publicado: (2017)

SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity
por: Mohn, Kristin G-I, et al.
Publicado: (2023)

Antigen-Specific IP-10 Release Is a Sensitive Biomarker of Mycobacterium bovis Infection in Cattle
por: Parsons, Sven D. C., et al.
Publicado: (2016)

Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis: Specific Immunity in Young Children
por: Jenum, Synne, et al.
Publicado: (2016)

Kinetics of Granuloma, IFN-γ and IP-10 in a Wistar Rat Model Infected with Mycobacterium Tuberculosis
por: Singh, Bobby, et al.
Publicado: (2022)

Human Immunodeficiency Virus–Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
por: Meyer-Myklestad, Malin Holm, et al.
Publicado: (2020)

Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis
por: Kim, Song Yee, et al.
Publicado: (2018)

Quantitation of 5-Methyltetrahydrofolic Acid in Dried Blood Spots and Dried Plasma Spots by Stable Isotope Dilution Assays
por: Kopp, Markus, et al.
Publicado: (2015)

Quantification of Zonisamide in Dried Blood Spots and Dried Plasma Spots by UPLC–MS/MS: Application to Clinical Practice
por: Rmandić, Milena, et al.
Publicado: (2022)

Identification of host biomarkers from dried blood spots for monitoring treatment response in extrapulmonary tuberculosis
por: Khalid, Shizza, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0bcd5e14jdki4nq922mi3r0eo6